Merck currently has the standard of care treatment for GBM with Temodar, but according to this article, IMUC looks as though have have a much improved option in development.http://www.biomedreports.com/2011122086123/improved-treatmen...
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar